Background Graft-versus-host disease (GVHD) is a common fatal complication of
hematopoietic stem cell transplantation (HSCT), where steroids are used as a treatment …

Hematopoietic cell transplantation (HCT) is a potentially curative treatment for many
hematologic and nonhematologic disorders. Graft-versus-host-disease (GVHD) in its acute …

Introduction Acute graft versus host disease (aGVHD) is a potentially lethal complication
after allogeneic stem cell transplantation. Biomarkers are used to estimate the risk of aGVHD …

Acute graft-versus-host disease (GVHD) is a major cause of mortality in patients undergoing
hematopoietic cell transplantation (HCT) for hematologic malignancies. The skin is the most …

Introduction. Psoriasis is a chronic inflammatory skin disease and is the result of the
interaction between numerous external and internal factors. Psoriasis presents a wide range …

Background and objective: Graft versus host disease (GVHD) is the common complication
seen after allogeneic hematopoietic stem cell transplantation (HSCT) and a pleomorphic …

A crucial complication after allogeneic hematopoietic cell transplantation (alloHCT), namely,
acute graft-versus-host disease (aGVHD), occurs in about 50% of transplant recipients …

Graft-versus-host disease (GvHD) remains a potentially fatal complication following
intestinal transplant (ITx). Over the past decade, advances in the understanding of the …

Chronic graft-versus-host disease (cGVHD), a potentially debilitating complication of
hematopoietic cell transplantation, confers increased risk for mortality. Whereas treatment …

Background Severe graft versus host disease (GVHD) is the main reason for non-relapse
mortality following allogeneic hematopoietic cell transplantation (HCT). We investigated the …